{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:28:58Z","timestamp":1760142538228,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.annfar.2013.11.011","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T20:46:28Z","timestamp":1388781988000},"page":"44-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Surdosage en dabigatran chez un patient en insuffisance r\u00e9nale\u00a0: int\u00e9r\u00eat et limites de l\u2019h\u00e9modialyse"],"prefix":"10.1016","volume":"33","author":[{"given":"B.","family":"Bachellerie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Conil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Crognier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Georges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2013.11.011_bib0005","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/ALN.0b013e318289bcba","article-title":"Managing new oral anticoagulants in the perioperative and intensive care unit setting","volume":"118","author":"Levy","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2013.11.011_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.annfar.2011.06.018","article-title":"Chirurgies et actes invasifs chez les patients trait\u00e9s au long cours par un anticoagulant oral anti-IIa ou anti-Xa direct\u00a0: propositions du Groupe d\u2019int\u00e9r\u00eat en h\u00e9mostase p\u00e9riop\u00e9ratoire (GIHP) et du Groupe d\u2019\u00e9tudes sur l\u2019h\u00e9mostase et la thrombose (GEHT)","volume":"30","author":"Sie","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.annfar.2013.11.011_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40262-013-0049-6","article-title":"Pharmacometric characterization of dabigatran hemodialysis","volume":"52","author":"Liesenfeld","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 1","key":"10.1016\/j.annfar.2013.11.011_bib0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jth.12227","article-title":"The role of the laboratory in treatment with new oral anticoagulants","volume":"11","author":"Baglin","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2013.11.011_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-9560-11-8","article-title":"New oral anticoagulants: discussion on monitoring adherence should start now","volume":"11","author":"Ten Cate","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.annfar.2013.11.011_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1160\/TH12-03-0179","article-title":"Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers","volume":"108","author":"Marlu","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2013.11.011_bib0035","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2011-11-393587","article-title":"Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding","volume":"119","author":"Warkentin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2013.11.011_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1160\/TH12-05-0330","article-title":"Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban","volume":"108","author":"Levi","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2013.11.011_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.ajkd.2012.08.047","article-title":"Removal of dabigatran by hemodialysis","volume":"61","author":"Chang","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765813012227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765813012227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:18:54Z","timestamp":1760091534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765813012227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0750765813012227"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2013.11.011","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surdosage en dabigatran chez un patient en insuffisance r\u00e9nale\u00a0: int\u00e9r\u00eat et limites de l\u2019h\u00e9modialyse","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}